Search Within

Christopher G Azzoli

  1. "Elsevier Inc."
Formats
  1. Journal Article (21)
  2. Meeting Abstract (9)
Groups
  1. Department of Medicine (25)
  2. Solid Tumor Oncology Division (25)
  3. Thoracic Oncology (23)
  4. Survivorship Research (12)
  5. Surgery (10)
  6. Department of Pathology and Laboratory Medicine (9)

More Groups

People
  1. Mark Kris (23)
  2. Vincent Miller (13)
  3. Gregory Riely (11)
  4. Lee Krug (11)
  5. Naiyer Rizvi (11)
  6. Michelle Ginsberg (8)

More People

Years
  1. 2014 (1)
  2. 2013 (3)
  3. 2012 (6)
  4. 2011 (7)
  5. 2010 (1)
  6. 2009 (4)

More Years

Publications
  1. Journal of Thoracic Oncology (26)
  2. Seminars in Oncology (2)
  3. Clinical Lung Cancer (1)
  4. Seminars in Thoracic and Cardiovascular Surgery (1)
Publishers
  1. Elsevier Inc. (30)

Results (30)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutation
    Journal Article

    Chaft, J. E.; Litvak, A.; Arcila, M. E.; Patel, P.; D'Angelo, S. P.; Krug, L. M.; Rusch, V.; Mattson, A.; Coeshott, C.; Park, B.; more...
    Clinical Lung Cancer (2014)

    Fulltext@MSK | Save
  • A phase II trial of paclitaxel, pemetrexed and bevacizumab in patients with untreated, advanced lung cancers
    Meeting Abstract

    Pietanza, M. C.; Hellmann, M. D.; Rizvi, N.; Azzoli, C. G.; Smith-Marrone, S.; Fiore, J.; Tyson, L. B.; Sumner, D. K.; Hergianto, A. B.; Kass, S. L.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers
    Journal Article

    Chaft, J. E.; Rusch, V.; Ginsberg, M. S.; Paik, P. K.; Finley, D. J.; Kris, M. G.; Price, K. A. R.; Azzoli, C. G.; Fury, M. G.; Riely, G. J.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors
    Journal Article

    Yu, H. A.; Sima, C. S.; Huang, J.; Solomon, S. B.; Rimner, A.; Paik, P.; Pietanza, M. C.; Azzoli, C. G.; Rizvi, N. A.; Krug, L. M.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • The select study: A multicenter phase II trial of adjuvant erlotinib in resected epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Neal, J. W.; Pennell, N. A.; Govindan, R.; Heist, R. S.; Shaw, A. T.; Muzikansky, A.; Jänne, P. A.; Lynch, T. J.; Azzoli, C. G.; Sequist, L. V.
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Distinct clinical course of EGFR-mutant resected lung cancers: Results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib
    Journal Article

    D'Angelo, S. P.; Janjigian, Y. Y.; Ahye, N.; Riely, G. J.; Chaft, J. E.; Sima, C. S.; Shen, R.; Zheng, J.; Dycoco, J.; Kris, M. G.; more...
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Clinical outcomes with perioperative chemotherapy in sarcomatoid carcinomas of the lung
    Journal Article

    Chaft, J. E.; Sima, C. S.; Ginsberg, M. S.; Huang, J.; Kris, M. G.; Travis, W. D.; Azzoli, C. G.
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with non-small-cell lung cancer
    Journal Article

    Pietanza, M. C.; Gadgeel, S. M.; Dowlati, A.; Lynch, T. J.; Salgia, R.; Rowland, K. M. Jr; Wertheim, M. S.; Price, K. A.; Riely, G. J.; Azzoli, C. G.; more...
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Screening for germline EGFR T790M mutations through lung cancer genotyping
    Journal Article

    Oxnard, G. R.; Miller, V. A.; Robson, M. E.; Azzoli, C. G.; Pao, W.; Ladanyi, M.; Arcila, M. E.
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Randomized phase 2b study of pralatrexate versus erlotinib in patients with stage IIIB/IV non-small-cell lung cancer (NSCLC) after failure of prior platinum-based therapy
    Journal Article

    Kelly, K.; Azzoli, C. G.; Zatloukal, P.; Albert, I.; Jiang, P. Y. Z.; Bodkin, D.; Pereira, J. R.; Juhász, E.; Iannotti, N. O.; Weems, G.; more...
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save